Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, NC 27834. NDC 51862-858-01
Published March 18, 2020 · Recall initiated: March 2, 2020
Summary
FDA records drug Class II recall D-0998-2020, published March 18, 2020 and initiated March 2, 2020. Recalling firm: Mayne Pharma Inc; Status: Terminated; Reported quantity: 8274 100-count bottles; Lot: Lot: FG11514 Exp. 05/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Product Mix-Up: A foreign tablet was found in bottle.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Mayne Pharma Inc
- Distributor
- Distributed Nationwide in the USA
- Lot
- Lot: FG11514 Exp. 05/2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAClonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04), Rx only,June 29, 2022
- FDALexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY, Distributed by: Mayne PharmaJanuary 26, 2022
- FDASunstar GUM Toothpaste 3 g tubes, Toothpaste made in Japan, packed in China, NDC 53050-0002-01March 18, 2020
- FDAQuetiapine Fumarate Extended-Release Tablets, 50 mg, 100 tablets per unit dose carton, Rx only, ManufacturedMarch 18, 2020
- FDAOxycodone and Acetaminophen Tablets, USP, 5 mg*/325 mg, 100-count bottle, Rx Only, Manufactured by: MayneSeptember 5, 2018
- FDAFabior (tazarotene) Foam, 0.1%, 100 grams can, Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834;April 11, 2018
Questions about this recall
Was Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, NC 27834. NDC 51862-858-01 recalled?
Yes. FDA published recall D-0998-2020 on March 18, 2020. Reported hazard: Product Mix-Up: A foreign tablet was found in bottle.
What should I do if I have this product?
Voluntary: Firm initiated · Letter